 |
|
 |
 |

Home > Company Index > Drugs > Drug Manufacturers - Major > Bristol-Myers Squibb Company
 |
Bristol-Myers Squibb Company |
 |
 |
 |
NEWS FROM THE WIRES |
 |
WRAPUP 1-Bayer pulls Baycol in Japan, legal woes hit stock Aug 23 2001 06:34 AM PDT
CBOE stats - U.S. equity options daily data Aug 23 2001 06:34 AM PDT
Roche says near Brazil accord on AIDS drug price Aug 23 2001 05:19 AM PDT
Lilly, Isis in reseach pact worth more than $300 mln Aug 22 2001 05:03 AM PDT
Bayer pharma bidders seen stalling on Baycol fears Aug 21 2001 09:53 AM PDT
> More WIRE STORIES about this company
NEWS FROM THE STANDARD |
 |
Drug Makers' Virtual Schmooze
Jun 12 2001 10:42 AM PDT
Bristol-Myers to Buy DuPont Drug Unit for $7.8 Billion
Jun 07 2001 05:22 PM PDT
After the Bell: Compaq Gains Following Earnings News
Jan 23 2001 05:17 PM PST
PROFILE |
 |
Bristol-Myers Squibb is perhaps best known to the public as a stalwart of the personal care industry. Among its market-leading products are Clairol and Excedrin, but a majority of sales come from pharmaceuticals. The company focuses its efforts on cardiovascular treatments, anti-infective drugs, and cancer-fighting products; cholesterol-reduction drug Pravachol is its best-selling drug and cancer treatment TAXOL is #2. Bristol-Myers Squibb also makes baby formulas, wound treatments, and orthopedic products. The company is purchasing the pharmaceutical business of DuPont, which will give its drug pipeline a boost it sorely needs.
COMPETITION |
 |
Aventis (AVE)
GlaxoSmithKline plc (GSK)
Merck & Co., Inc. (MRK)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 18,216.00
1-Yr. Sales Growth: (9.9)%
Employees: 44,000
Revenue per employee: $414,000.00
KEY PEOPLE |
 |
Peter R. Dolan
CEO
Frederick S. Schiff
CFO
CONTACT INFO |
 |
345 Park Ave.
New York, NY 10154
US
Phone: 212-546-4000
Fax: 212-546-4020
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |